ImmunityBio
IBRX
IBRX
126 hedge funds and large institutions have $311M invested in ImmunityBio in 2021 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 51 increasing their positions, 26 reducing their positions, and 16 closing their positions.
Holders
126
Holders Change
+1
Holders Change %
+0.8%
% of All Funds
2.21%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
20
Increased
51
Reduced
26
Closed
16
Calls
$5.03M
Puts
$13M
Net Calls
-$7.96M
Net Calls Change
+$3.73M
Top Buyers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$68.5M |
2 |
2
State Street
Boston,
Massachusetts
|
$51.8M |
3 |
![]()
3
JPMorgan Chase & Co
New York
|
$11.6M |
4 |
PAMS
4
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
$3.03M |
5 |
5
D.E. Shaw & Co
New York
|
$3.68M |